Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SINGAPORE AIRLINES LIMITED (C6L)

  • Business News
  • June 25, 2026, 00:28 UTC
  • 3
  • 0 comments

Annual Reports and Related Documents:

Market reaction Comment Full text

RH PETROGAS LIMITED (T13)

  • Business News
  • June 25, 2026, 00:28 UTC
  • 4
  • 0 comments

General Announcement: RH Petrogas Commences Drilling of Northwest Klagagi-1 Well in Kepala Burung PSC

Market reaction Comment Full text

SINGAPORE AIRLINES LIMITED (C6L)

  • Business News
  • June 25, 2026, 00:27 UTC
  • 5
  • 0 comments

Annual General Meeting :

Market reaction Comment Full text

FIRST SOLAR, INC. (FSLR)

  • Business News
  • June 25, 2026, 00:27 UTC
  • 8
  • 1 comments

Securities Fraud Investigation Into First Solar, Inc. (FSLR) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

Market reaction Comment Full text

FORTIVE CORP (FTV)

  • Business News
  • June 25, 2026, 00:18 UTC
  • 6
  • 1 comments

Advanced Sterilization Products (ASP) erwirbt Mehrheitsbeteiligung an UV Smart

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • June 25, 2026, 00:05 UTC
  • 7
  • 1 comments

[Press Release] HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO GI 2026

Market reaction Comment Full text

ALLEGIANT TRAVEL CO (ALGT)

  • Business News
  • June 25, 2026, 00:05 UTC
  • 5
  • 1 comments

ALLEGIANT TRAVEL COMPANY ISSUES SENIOR SECURED NOTES

Market reaction Comment Full text

AJJ MEDTECH HOLDINGS LIMITED (584)

  • Business News
  • June 25, 2026, 00:00 UTC
  • 2
  • 0 comments

General Announcement: Update on AI-Enabled Eldercare Robotics, RR-CARE Framework and Research Progress

Market reaction Comment Full text

HUTCHMED (CHINA) LTD (HCM)

  • Business News
  • June 25, 2026, 00:00 UTC
  • 5
  • 1 comments

HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • June 24, 2026, 23:55 UTC
  • 5
  • 1 comments

Mesoblast Draws US$50M from Five-Year Non-Dilutive Facility

Market reaction Comment Full text
  • Previous
  • 3058
  • 3059
  • 3060
  • 3061
  • 3062
  • Next

Search

News categories

  • Technical Exchange News(14412)
  • Event(6229)
  • SEC News(376297)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(230297)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin